Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Receivables - Net: 2015-2025

Historic Receivables - Net for Fortress Biotech (FBIO) over the last 10 years, with Sep 2025 value amounting to $18.0 million.

  • Fortress Biotech's Receivables - Net rose 68.52% to $18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year increase of 68.52%. This contributed to the annual value of $10.2 million for FY2024, which is 32.79% down from last year.
  • Latest data reveals that Fortress Biotech reported Receivables - Net of $18.0 million as of Q3 2025, which was up 14.95% from $15.6 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Receivables - Net ranged from a high of $31.7 million in Q3 2021 and a low of $8.0 million during Q3 2023.
  • In the last 3 years, Fortress Biotech's Receivables - Net had a median value of $12.9 million in 2023 and averaged $14.4 million.
  • In the last 5 years, Fortress Biotech's Receivables - Net spiked by 259.98% in 2021 and then tumbled by 72.00% in 2023.
  • Over the past 5 years, Fortress Biotech's Receivables - Net (Quarterly) stood at $23.1 million in 2021, then rose by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then tumbled by 32.79% to $10.2 million in 2024, then spiked by 68.52% to $18.0 million in 2025.
  • Its Receivables - Net stands at $18.0 million for Q3 2025, versus $15.6 million for Q2 2025 and $18.0 million for Q1 2025.